E-drug: Cardiovascular Guidelines Ed 4
---------------------------------------------
'Therapeutic Guidelines Ltd' released the 4th edition of
Cardiovascular Guidelines in August: Therapeutic Guidelines
Cardiovascular 4.
Major revisions in this new edition cover:
� Primary and secondary prevention of atheromatous disease
� A list of cardiovascular risk assessment tools
� An increased emphasis on preventing and dealing with the decline of
renal function (with or without diabetes)
� Treatment of heart failure, with the emphasis on improving prognosis
� Coronary pain syndromes including newer drugs for managing the
acute phase and the increasing use of early revascularisation for
high-risk patients
� Pre-eclampsia including the significant therapeutic findings from a
recent large study
� Uncomplicated benign hypertension - endorsement from a review of
trial evidence for diuretics as the most cost-effective initial
treatment
� Assessment and treatment of smoking
Also:
� Updated information on dyslipidaemia; hypertension; hypertension
and cardiovascular disease in pregnancy; arrhythmias; peripheral
vascular and cerebrovascular disease; venous thrombosis and pulmonary
embolism
� Appendices on cardiovascular drug interactions, etc.
'Therapeutic Guidelines Ltd' is an Australian not for profit
organisation that has become well known internationally, particularly
for the production of Antibiotic, Psychotropic and Analgesic
guidelines as well as a range of other titles. These guidelines are
independent, peer reviewed and regularly updated. Sales of products
sustain the continuation of the organisation and development of more
guidelines. There is no sponsorship!
More details can be found at
http://www.tg.com.au
For more information contact
Enid Meldrum
Therapeutic Guidelines Limited
2/55 Flemington Rd.,
North Melbourne. Vic Australia 3051